Reviving an R&D Pipeline
DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence - Ein Podcast von DrugPatentWatch
Kategorien:
The article titled “Reviving an R&D Pipeline: A Step Change in the Phase II Success Rate” discusses Pfizer’s efforts to improve its research and development (R&D) productivity. The pharmaceutical industry has faced declining R&D productivity, and Pfizer aimed to address this challenge by focusing on three key areas: biology, modalities, and decision-making. Key Points Background: […] Source
